In summary, our study provides strong evidence linking class IA PI3K and autophagy with the maintenance of HSC differentiation and suggests that further studies are needed to explore metformin and other autophagy inducers as a potential therapeutic approach for MDS. This evidence concerns the gene PIK3CA and myelodysplastic syndrome.